Healthcare -
Biotechnology - NASDAQ - BM
$ 29.76
2.22 %
$ 2.17 B
Market Cap
-118.08
P/E
KNSA - OPERATING INCOME
Operating Income KNSA - Kiniksa Pharmaceuticals, Ltd.
-45.6 M
LAST VALUE
-168.12%
2 YEAR CAGR
23.13%
5 YEAR CAGR
0.00%
10 YEAR CAGR